OIA
EDIT icon

Optimum Investment Advisors’s Editas Medicine EDIT Stock Holding History

Optimum Investment Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-65
Closed -$1K – 958
2019
Q3 		$1K Buy
+65
New +$1.61K ﹤0.01% 956

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Optimum Investment Advisors's EDIT Position: Q4 2019 in Review

Optimum Investment Advisors sold out of Editas Medicine (EDIT) in Q4 2019, closing a stake of 65 shares — an estimated $1K sold.

Optimum Investment Advisors first reported a position in EDIT in Q3 2019 and held it in 1 quarter. The position peaked at $1K in Q3 2019. 229 funds tracked by Wall St. Rank hold EDIT as of Q4 2019.

  • Optimum Investment Advisors reported no remaining Editas Medicine position as of Q4 2019 after selling out during the quarter.
  • Optimum Investment Advisors sold 65 Editas Medicine shares in Q4 2019, an estimated $1K.
  • Optimum Investment Advisors first reported a position in Editas Medicine in Q3 2019 and held it in 1 quarter.
  • Optimum Investment Advisors's Editas Medicine position peaked at $1K in Q3 2019.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2019.

Based on Optimum Investment Advisors's 13F filing for Q4 2019, filed 22 Jan 2020.